The initial deductible on prescription drug reimbursements will change, affecting medication costs for many
Parliament has approved changes to the initial deductible on reimbursements of medicine costs. The initial deductible will go up from 50 euros to 70 euros in January 2025. In addition, the initial deductible will be tied to the National Pensions Index and will be reviewed annually.
Parliament has approved the changes the Government proposed to the initial deductible on reimbursements of prescription medicine costs. The Government seeks to lower reimbursement spending by 90 million euros.
On 1 January 2025, the initial deductible on reimbursements of medicine costs will go up from 50 euros to 70 euros. In addition, the initial deductible will be tied to the National Pensions Index, so that it will be index adjusted every year.
"The National Pensions Index reflects changes in the general cost of living”, says Vilja Juvonen, a legal counsel at Kela. “If the cost of living rises, so does the National Pensions Index, in turn increasing the initial deductible.”
Kela provides reimbursements for the costs of medicinal products, clinical nutritional products and emollient creams that have been prescribed for the treatment of an illness. Costs exceeding an annual initial deductible can be reimbursed. The initial deductible is applied from the beginning of the year in which a person turns 19.
The amount reimbursed depends on the specific medicine and the reimbursement entitlements granted. There are three categories of reimbursement: basic, lower special and higher special.
Fewer people will receive reimbursements as a result of the higher initial deductible
In 2023, about 55% of Finns, a little over 3 million persons, qualified for reimbursement of prescription medicine costs. Total expenditure on the reimbursements amounted to 1,779 million euros, most of which was accounted for by the reimbursements in the higher special category. Over-65s were the single largest group of reimbursement recipients.
“The higher initial deductible will have the greatest impact on those who need medicines in the higher special reimbursement category. The people who need such medicines often have multiple illnesses, little income and are on average older than others who purchase medicines”, Juvonen says.
The number of reimbursement recipients has increased over the past few years. In 2023, the number of recipients was up by 1.7% (a little over 51,000) year-on-year. In 2022, the number of reimbursement recipients grew by 84,000.
“We estimate that the higher initial deductible will reduce the number of reimbursement recipients by about 226,000. The under-45 age groups will have the largest number of people who do not clear the initial deductible threshold”, Juvonen says.
The changes in the initial deductible will go into effect automatically. The process of claiming reimbursement for medicine costs will remain unchanged.
Typically, the reimbursement is calculated off the price of the medicine at the pharmacy. If this is not the case or if a customer had to buy medicine before Kela had granted them a right to reimbursement, the reimbursement must be claimed afterwards from Kela.
Customers do not have to do anything in response to the change and do not need to contact Kela.
Learn more
Contacts
Vilja JuvonenLegal CounselKela
Tel:050 476 4144firstname.lastname@kela.fiKela's Communications UnitFor media enquiries, please contact us between 9:00 and 16:00, Monday to Friday. This number can be used for interview requests, which we will be happy to forward to an appropriate source at Kela. You can also submit interview requests by email.
Tel:+358 20 634 7745viestinta@kela.fiAlternative languages
Subscribe to releases from Kela/FPA
Subscribe to all the latest releases from Kela/FPA by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Kela/FPA
FPA:s fullmäktige hörde generaldirektör Lasse Lehtonen27.11.2025 10:08:32 EET | Pressmeddelande
FPA:s fullmäktige hörde FPA:s generaldirektör Lasse Lehtonen med anledning av hans senaste offentliga uttalanden och ledningssituationen inom FPA. Under mötet diskuterades också de riktlinjer som medför minskat distansarbete och som träder i kraft i början av året.
Kelan valtuutetut kuulivat pääjohtaja Lasse Lehtosta27.11.2025 10:08:32 EET | Tiedote
Kelan valtuutetut kuulivat Kelan pääjohtaja Lasse Lehtosta hänen viimeaikaisista julkisista ulostuloistaan ja Kelan johtamistilanteesta. Keskustelua käytiin myös lähityön lisäämiseen liittyvistä linjauksista, jotka tulevat voimaan alkuvuonna.
Kutsu mediatilaisuuteen 27.11.: Mira Nieminen vastaa median kysymyksiin26.11.2025 12:54:06 EET | Kutsu
Kelan valtuutettujen puheenjohtaja Mira Nieminen vastaa median kysymyksiin valtuutettujen kokouksen jälkeen 27.11. Teams-kokouksessa. Nieminen ei kommentoi asiaa ennen kokousta.
Muutos käytäntöön vaativan lääkinnällisen kuntoutuksen terapiapalveluiden sopimuskauden vaihtuessa24.11.2025 14:18:26 EET | Tiedote
Kela kilpailuttaa vaativan lääkinnällisen kuntoutuksen terapiat vuonna 2026, ja uusien sopimusten mukaiset terapiat alkavat 1.1.2027. Vaikka asiakkaan kuntoutuspäätöksessä nimetty palveluntuottaja ei saisi sopimusta uudelle sopimuskaudelle, voi palveluntuottaja halutessaan jatkaa asiakkaan terapiaa asiakkaan kuntoutuspäätöksen loppuun asti.
FPA:s chattbottar svarar nu också på frågor om sjukdagpenningar24.11.2025 13:03:22 EET | Pressmeddelande
Chattbottarna FPA-Folke och FPA-Kelpo kan nu också svara på frågor om FPA:s sjukdagpenningar. FPA:s chattbottar ger kunderna information om dagpenningar som betalas på grundval av arbetsoförmåga samt råd om ansökningsprocessen och om de bilagor som behövs för ansökan.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom